| CENTER ID: | ChtrB.00163.a |
| ORGANISM: | Chlamydia trachomatis D/UW-3/Cx |
| ASSOCIATED DISEASE: | |
| CURRENT STATUS: | expressed |
| COMMUNITY REQUEST: | True |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
non-BEI |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| ChtrB.00163.a.B4.GE42575 | truncation 3 | 89 | 342 |
| METHOD | RESULTS |
|---|---|
| comparative modelling | Robetta_82008 |
| de-novo with evolutionary constraints | ModelArchive_ma-4jcjk |
| RESOURCE | REFERENCE ID |
|---|---|
| BV-BRC: | fig|272561.5.peg.923 |
| UniProt: | O84843 |
| HARVESTED ON: | 8/5/2018 |
| SEQUENCED ON: | 8/8/2018 |
| EXPECTED MW: | 30kDa |
| OBSERVED MW: | 30kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Insoluble |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 99 |
| PERCENT COVERAGE: | 100 |